This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Pulmonary Arterial Hypertension
and you are
over 18
years old
Phase
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

In this prospective study, the investigators will implement a systematic screening program and 3-year follow-up in a cohort of asymptomatic BMPR2 mutation carriers. This study is designed to: - determine predictive factors (biological, functional, radiological and hemodynamic) of development of PAH - monitor these subjects' clinical, functional, biological, echocardiographic and hemodynamic characteristics - assess the risk of occurrence of PAH - screen patients with PAH at an early stage of disease and offer them an early management - constitute a collection of biological samples (0, 12, 24 months follow-up) of asymptomatic BMPR2 mutation carriers.
Tris trial is registered with FDA with number: NCT01600898. The sponsor of the trial is Assistance Publique - Hôpitaux de Paris and it is looking for 57 volunteers for the current phase.
Official trial title:
Screening and Risk Factors of Pulmonary Arterial Hypertension in BMPR2 Mutation Asymptomatic Carriers